NCT07653139Enrolling by invitation
Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This study aims to generate structured patient preference evidence on prophylactic treatment options for haemophilia A for adults with and without inhibitors to support health technology assessment and benefit evaluation processes. The study will examine how individuals with haemophilia A evaluate trade-offs between treatment effectiveness, safety, and treatment administration characteristics when choosing between prophylactic therapies. Participants will repeatedly choose between hypothetical treatment profiles that differ in clinically relevant attributes and levels.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 3 Jun 2026
- Start date
- Sept 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Haemophilia
- NCT number
- NCT07653139
What you commit to
- Study type: Observational
- Planned participants: 150
- From Sept 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age below 18 years at the time of signing informed consent.
Other
- No provision of informed consent in this study.
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Absence of a diagnosis of haemophilia A.
- No residence in Germany.
Who the study is looking for
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Participant has the mental capacity and sufficient German language proficiency to understand the study procedures and to complete the survey.
- Age above or equal to 18 years at the time of signing informed consent.
- Validated diagnose with haemophilia A, with and without inhibitors.
- Resident in Germany.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Mainz | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.